Understanding supplements.
How do I evaluate what you're actually buying — in the aisle built on a word immunology doesn't use?
The immune aisle sells a verb — 'boost' — that the field it invokes does not recognize: immunology's diseases of immune excess are allergy and autoimmunity, and the system pushed past its regulation is the pathology, not the goal. Beneath the verb sit the honest three: the receptor vitamin (test-guided D3), the deficiency gate (maintenance zinc, the acute lozenge protocol), and the overpromised classic (C, graded against Cochrane). And around them: the 'immune defense complexes' — kitchen-sink blends that routinely pack zinc above the 40 mg ceiling alongside megadose C and token botanicals, the copper paradox on a subscription. Evaluation here is one discipline: find the population, the dose, and the formulation behind every claim — and retire the word on the label.
D3 Softgels
Test-guided, daily, with fat
Zinc 15 mg Capsules
Maintenance — the ceiling respected
Zinc Lozenges
The cold protocol — right salt, acute only
'Immune Defense Complexes'
The kitchen sink — zinc over the ceiling
D3 (Cholecalciferol) ✅
The skin-synthesis form, superior to D2 at raising and sustaining blood levels — the standard choice across this library. Daily dosing outperformed the megadose bolus arms in the respiratory-infection meta-analysis: the pattern, not the pulse. Fat-soluble — with a fat-containing meal.
The Sun vs. The Capsule
Skin makes D3 under UVB — and sunscreen rightly blocks the reaction (our skin page's factory loop). Deliberate sunburn for a vitamin is the worst trade on the estate: supplement the level, protect the skin. The test decides; the capsule supplies; the sunscreen stays.
Choosing the Right Form & Dose
Label literacy in the immune aisle has four specific jobs:
- The zinc arithmetic first: find the zinc dose, add every source (the capsule, the multivitamin, the diet) — under 40 mg chronic, always. The single most important number on any 'immune formula' label.
- The D level before the D dose: the test decides — deficient correction is the evidence's home turf; blanket megadosing is not (the bolus arms underperformed).
- The lozenge salt check: for the cold protocol, acetate or gluconate (ionic release), 75 mg+, within 24 hours, days only — the chemistry is the product.
- The population read on every claim: C's prevention is the extreme-exerciser's; D's protection is the deficient's; zinc's cold effect is the right-formulation user's. A label without its population is a claim without its evidence.
- The standing rule: third-party verification (USP, NSF, ConsumerLab) — in the category with the industry's boldest claims, the verified label is the minimum credential, not the differentiator.
Red Flags to Watch For
The immune market sells the verb immunology retired. Be highly cautious of products that:
- Lead with 'immune boost,' 'immune armor,' 'activate your defenses' — the marketing word for the disease states of immune excess; the category's founding fiction.
- Pack zinc at 50 mg+ daily defaults — above the ceiling, below the honesty: the copper paradox sold as a feature (the most common hard-harm product on the aisle).
- Claim megadose C prevention — the Cochrane null is five decades deep; the extreme-exercise subset on the label is borrowed from a population the buyer is almost certainly not.
- Insinuate vaccine substitution — the gravest harm path the category touches; the measles resurgence is the current invoice. Any product or influencer in this territory is disqualified entirely, not downgraded.
- Sell unstandardized elderberry and 'immune berry' blends — the content-not-dose problem (the cranberry lesson's cousin), with small-trial evidence at category-scale confidence.
- Lack third-party verification (USP, NSF, ConsumerLab) — with the boldest claims on the aisle, the unverified label is the unassessed dose.